Cuong Ton
Psychiatry · Tampa, FLNPI 1508259730
Payments from drug & device makers
Across 234 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$671
- AbbVie$605
- Neurocrine Biosciences, Inc.$533
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$375
- Vanda Pharmaceuticals Inc.$304
- Idorsia Pharmaceuticals US Inc$259
- plus $977 from 15 others
What the payments were for
- Food & beverage$3,67699%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 46 | $671 |
| AbbVie | 35 | $605 |
| Neurocrine Biosciences, Inc. | 43 | $533 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $375 |
| Vanda Pharmaceuticals Inc. | 16 | $304 |
| Idorsia Pharmaceuticals US Inc | 13 | $259 |
| Eisai Inc. | 20 | $193 |
| Sunovion Pharmaceuticals Inc. | 11 | $190 |
| Corium, LLC | 9 | $134 |
| Alkermes, Inc. | 6 | $130 |
| Avanir Pharmaceuticals, Inc. | 3 | $57 |
| Tris Pharma Inc | 2 | $39 |
| Neos Therapeutics, LP | 2 | $38 |
| Alfasigma USA, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| Almatica Pharma LLC | 1 | $22 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$124
How this compares
$3,723 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $408 |
| Zolpidem Tartrate | 12 | $121 |
| Clonazepam | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Tampa
- Kelley WilsonTampa$11.1M
- Jamie FernandezTampa$2.9M
- Jean FilsTampa$1.1M
- Daniel FallonTampa$724K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.